Regulatory Exclusivity: NEW INDICATION
✉ Email this page to a colleague
Drugs with New Indication Regulatory Exclusivity
Click here to exclude patents covering these drugs from this list
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | Patent No. | Patent Expiration | Exclusivity Expiration | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | BRILINTA | ticagrelor | 022433 | Sep 3, 2015 | RX | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | REDUCE THE RISK OF STROKE IN PATIENTS WITH ACUTE ISCHEMIC STROKE (NIH STROKE SCALE SCORE |
| Astrazeneca | BRILINTA | ticagrelor | 022433 | Sep 3, 2015 | RX | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | REDUCE THE RISK OF STROKE IN PATIENTS WITH ACUTE ISCHEMIC STROKE (NIH STROKE SCALE SCORE |
| Astrazeneca | BRILINTA | ticagrelor | 022433 | Sep 3, 2015 | RX | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | REDUCE THE RISK OF STROKE IN PATIENTS WITH ACUTE ISCHEMIC STROKE (NIH STROKE SCALE SCORE |
| Astrazeneca | BRILINTA | ticagrelor | 022433 | Sep 3, 2015 | RX | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | REDUCE THE RISK OF STROKE IN PATIENTS WITH ACUTE ISCHEMIC STROKE (NIH STROKE SCALE SCORE |
| Astrazeneca | BRILINTA | ticagrelor | 022433 | Jul 20, 2011 | RX | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | REDUCE THE RISK OF STROKE IN PATIENTS WITH ACUTE ISCHEMIC STROKE (NIH STROKE SCALE SCORE |
| >Applicant | >Tradename | >Generic Name | >NDA | >Approval Date | >Type | >Patent No. | >Patent Expiration | >Exclusivity Expiration | >Patented / Exclusive Use |
